Our Research & Development (R&D) teams research emerging diseases, develop of novel assays, and continually refine methodologies.
In recent years, our serology R&D team has produced more than 185 MFIA® tests to detect antibodies to 90 infectious agents in seven different species. In addition, our PCR R&D group has developed more than 160 TaqMan® assays to screen over 10 species.
recently completed projects
Learn more about our R&D efforts by visiting The SourceSM to read publications, view webinars and listen to podcasts.
R&D efforts are made possible through both in-house projects and collaborations with other institutions worldwide. If you have an idea for a R&D project, please contact us at firstname.lastname@example.org to explore the potential for a collaboration with our team.